Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Tysabri prescribing information
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Estimation of the effect of dalfampridine on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Multiple sclerosis and oligodendroglioma: an exceptional association.
[Optical coherence tomography in multiple sclerosis].
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Low-contrast visual tests reveal better alemtuzumab efficacy
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Physiopathology of symptoms and signs in multiple sclerosis.
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.

Pages